natgillin/translations-raw huggingface dataset:
In a meeting organised on 14 February 2012, the Commission in close collaboration with the Member States identified the priorities and areas for which additional information should be gathered prior to considering the development of veterinary legislation addressing this new infection.
Komisija je na sestanku 14. februarja 2012 v tesnem sodelovanju z državami članicami opredelila prednostne naloge in področja, za katera bi bilo treba zbrati dodatne informacije pred odločitvijo o razvoju veterinarske zakonodaje glede te nove okužbe.
These are in particular, the mechanism by which the disease is caused (pathogenesis), the epidemiology, notably focusing on transmission pathways, the host range, the role of vectors and reservoirs; and the confirmation of the non-zoonotic potential of this virus and the methods to diagnose the disease in animal samples and their validation.
Te informacije se nanašajo zlasti na mehanizme, ki povzročajo bolezen (patogeneza), epidemiologijo (s poudarkom na načinih prenosa), območje gostitelja, vlogo vektorjev in rezervoarjev, potrditev, da se ta virus ne more prenašati na ljudi, ter metode za diagnosticiranje bolezni v vzorcih živali in njihovo potrditev.
Belgium, Germany, Spain, France, Italy, the Netherlands and the United Kingdom have drawn up scientific studies intended to gain knowledge on Schmallenberg virus in the areas identified above and submitted them to the Commission on 5 March 2012, requesting EU financial support.
Belgija, Nemčija, Španija, Francija, Italija, Nizozemska in Združeno kraljestvo so pripravili znanstvene študije z dognanji o navedenih vprašanjih, povezanih z virusom Schmallenberg, ter jih 5. marca 2012 predložile Komisiji s prošnjo za finančno podporo EU.
Some of the scientific studies have been presented by several Member States in the form of a consortium, in these cases and for the purpose of clarity, one of the partners has been identified as coordinator of the consortium and responsible for communication with the Commission and transmission of technical reports.
Nekatere znanstvene študije je predložilo več držav članic skupaj v obliki konzorcija; v teh primerih je bil zaradi jasnosti eden od partnerjev določen za koordinatorja konzorcija, ki je pristojen za komuniciranje s Komisijo in pošiljanje tehničnih poročil.
Pursuant to Article 22 of Decision 2009/470/EC, the Union may undertake, or assist the Member States or international organisations in undertaking, the technical and scientific measures necessary for the development of EU veterinary legislation and for the development of veterinary education or training.
V skladu s členom 22 Odločbe 2009/470/ES lahko Unija izvaja ali državam članicam ali mednarodnim organizacijam pomaga pri izvajanju tehničnih in znanstvenih ukrepov, potrebnih za razvoj veterinarske zakonodaje EU in za razvoj izobraževanja ali usposabljanja na področju veterine.
A financial contribution should be granted to the studies on Schmallenberg virus implemented by Belgium, Germany, Spain, France, Italy, the Netherlands and the United Kingdom as the outcomes may lead to new insights on the subject mentioned above.
Študijam o virusu Schmallenberg, ki so jih pripravili Belgija, Nemčija, Španija, Francija, Italija, Nizozemska in Združeno kraljestvo, bi bilo treba odobriti finančni prispevek, saj bi njihovi rezultati lahko pripeljali do novih spoznanj o navedeni temi.
The Commission has evaluated all the proposals and selected those that matched with the agreed priorities.
Komisija je ocenila vse predloge in izbrala tiste, ki so ustrezali dogovorjenim prednostnim nalogam.
Considering the resources needed to develop the studies and the need to start as soon as possible the activities in order to get the results, it is appropriate to start financing them as from 1 April 2012.
Ob upoštevanju potrebnih sredstev za razvoj študij in potrebe po čim prejšnjem izvajanju dejavnosti, da se dosežejo rezultati, je primerno, da se začnejo financirati od 1. aprila 2012 dalje.
For financial control purposes, Articles 9, 36 and 37 of that Regulation are to apply.
Za finančni nadzor se uporabijo členi 9, 36 in 37 navedene uredbe.
The payment of the financial contribution shall be subject to the condition that the studies planned have actually been carried out and that the authorities supply all the necessary information to the Commission.
Plačilo finančnega prispevka se izvede pod pogojem, da se načrtovane študije dejansko izvedejo in da pristojni organi Komisiji zagotovijo vse potrebne informacije.
The Union shall grant Belgium, Germany, Spain, France, Italy, the Netherlands and the United Kingdom financial assistance for their scientific studies on Schmallenberg virus, as summarised in Annex I. The present decision constitutes a financing decision in the meaning of Article 75 of the Financial Regulation.
Unija odobri finančno pomoč Belgiji, Nemčiji, Španiji, Franciji, Italiji, Nizozemski in Združenemu kraljestvu za znanstvene študije o virusu Schmallenberg, kakor je povzeto v Prilogi I. Ta sklep predstavlja odločitev o financiranju v smislu člena 75 finančne uredbe.
The financial contribution by the Union
Finančni prispevek Unije:
shall be at the rate of 50 % of the eligible costs to be incurred by each Member State referred to in paragraph 1 for the studies listed in Annex I and in accordance with the budgets listed in Annex II, for the period 1 April 2012 to 31 December 2013;
znaša 50 % upravičenih stroškov, ki jih bo imela vsaka država članica iz odstavka 1 za študije iz Priloge I in v skladu s proračuni iz Priloge II, za obdobje med 1. aprilom 2012 in 31. decembrom 2013;
EUR 438615 for Belgium;
438615 EUR za Belgijo;
EUR 595883 for Germany;
595883 EUR za Nemčijo;
EUR 146590 for Spain;
146590 EUR za Španijo;
EUR 589380 for France;
589380 EUR za Francijo;
EUR 124120 for Italy;
124120 EUR za Italijo;
EUR 639342 for the Netherlands;
639342 EUR za Nizozemsko;
EUR 371811 for the United Kingdom;
371811 EUR za Združeno kraljestvo;
Belgium, Germany, Spain, France, Italy, the Netherlands and the United Kingdom, or in cases when the scientific studies are carried out by more than one Member State in a consortium, the coordinator Member State as listed in Annex I, shall submit to the Commission:
Belgija, Nemčija, Španija, Francija, Italija, Nizozemska in Združeno kraljestvo ali, kadar znanstvene študije izvaja več kot ena država članica v konzorciju, država članica koordinatorica iz Priloge I Komisiji predložijo:
no later than 31 March 2013 an intermediate technical report per project,
vmesno tehnično poročilo za posamezni projekt najpozneje do 31. marca 2013,
no later than 31 March 2014 a final technical report per project;
končno tehnično poročilo za posamezni projekt najpozneje do 31. marca 2014;
Belgium, Germany, Spain, France, Italy, the Netherlands and the United Kingdom shall submit to the Commission:
Belgija, Nemčija, Španija, Francija, Italija, Nizozemska in Združeno kraljestvo Komisiji predložijo:
no later than 31 March 2014 a paper version and an electronic version of their financial report drawn up in accordance with Annex IV.
finančno poročilo v papirni in elektronski različici, pripravljeno v skladu s Prilogo IV najpozneje do 31. marca 2014.
The supporting documents, evidencing all the expenditure referred to in the application for reimbursement, shall be sent to the Commission on request;
Dokazilne listine, ki upravičujejo vse odhodke iz vloge za povračilo, se na zahtevo pošljejo Komisiji;
the outcome of the studies must be made available to the Commission, all Member States and EFSA and presented at the Standing Committee on the Food Chain and Animal Health.
rezultati študije morajo biti na voljo Komisiji, vsem državam članicam in Efsi ter predstavljeni Stalnemu odboru za prehranjevalno verigo in zdravje živali.
The maximum overall contribution authorised by this Decision for the costs incurred for the work referred to in Article 1(1) is set at EUR 2905741 to be financed from the following budgetary line of the general budget of the European Union for 2012:
Najvišji skupni prispevek, odobren s tem sklepom, za stroške dela iz člena 1(1), v višini 2905741 EUR se financira iz proračunske vrstice splošnega proračuna Evropske unije za leto 2012:
budgetary line No 17 04 02 01.
proračunska vrstica št. 17 04 02 01.
Expenditure relating to staff dedicated to the projects, consumables, animal studies, travel costs linked to meetings and overheads shall be eligible within the limits set out in Article 1 and in accordance with the eligibility rules set out in Annex III.
Odhodki v zvezi z osebjem, ki dela na projektih, potrošnim blagom, študijami na živalih, potnimi stroški, povezanimi s sestanki, in režijskimi stroški so upravičeni v okviru omejitev iz člena 1 in v skladu s pravili o upravičenosti iz Priloge III.
The Union’s financial assistance shall be paid following presentation and approval of the reports and supporting documents referred to Article 1(2)(c) and (d).
Finančna pomoč Unije se plača po predložitvi in potrditvi poročil in dokazilnih listin iz člena 1(2)(c) in (d).
This Decision is addressed to the Kingdom of Belgium, the Federal Republic of Germany, the Kingdom of Spain, the French Republic, the Italian Republic, the Kingdom of the Netherlands and the United Kingdom of Great Britain and Northern Ireland.
Ta sklep je naslovljen na Kraljevino Belgijo, Zvezno republiko Nemčijo, Kraljevino Španijo, Francosko republiko, Italijansko republiko, Kraljevino Nizozemsko in Združeno kraljestvo Velika Britanija in Severna Irska.
Description of the technical and scientific studies on Schmallenberg virus (SBV), referred to in Article 1(1)
Opis tehničnih in znanstvenih študij o virusu Schmallenberg iz člena 1(1)
To identify the primary (and possibly secondary) replication sites and virus virulence in non-pregnant animals by experimental infection studies in young animals of cattle, sheep and goats.
Opredelitev primarnega (in po možnosti sekundarnega) mesta replikacije in virulence virusa pri nebrejih živalih s študijami z eksperimentalno okužbo mladega goveda, ovc in koz.
Member States involved: Belgium, Germany, France, the Netherlands and the United Kingdom.
Sodelujoče države članice: Belgija, Nemčija, Francija, Nizozemska in Združeno kraljestvo.
Coordinators: Sheep — the Netherlands, Goats — France
Koordinatorici: za ovce – Nizozemska, za koze – Francija.
To study the development of immunity to SBV by experimental infection studies in sero-positive as well as sero-negative animals of the different species.
Študija razvoja imunosti na virus Schmallenberg z eksperimentalno okužbo različnih vrst seropozitivnih in seronegativnih živali.
Coordinator: United Kingdom
Koordinatorica: Združeno kraljestvo.
Outcome for projects 1.1, 1.2 and 1.3:
Rezultati projektov 1.1, 1.2 in 1.3:
Data on pathogenesis, viremia duration, incubation time, virus distribution, virus shedding and possible persistence of Schmallenberg virus to be used for tests on live animals, generation of vaccines as well as collection of reference materials for tests’ validation.
podatki o patogenezi, trajanju viremije, inkubacijski dobi, distribuciji virusa, širjenju virusa in možni obstojnosti virusa Schmallenberg, namenjenega uporabi za preskuse pri živih živalih, pridobivanje cepiva in zbiranje referenčnega materiala za potrjevanje preskusov.
Outcome:
Rezultati:
Description of the current spread of SBV disease in the bovine and ovine population, the clinical consequences of SBV infection and the risk factors for introduction, transmission and morbidity in holdings and animals.
opis trenutne razširjenosti bolezni virusa Schmallenberg pri populaciji goveda in ovac, kliničnih posledic okužbe z virusom Schmallenberg ter dejavnikov tveganja za vnos, prenos in obolevnost na gospodarstvih in pri živalih.
Member States involved: Belgium
Sodelujoče države članice: Belgija.
Collection of SBV case data, baseline data on abortion, stillbirth and malformations and results of epidemiological studies (case/control study in cattle, sheep and goats; source identification study, seroprevalence study, sentinel study) to be provided to for meta-analyses of study results.
Zbiranje podatkov o primerih virusa Schmallenberg, izhodiščnih podatkov o splavu, mrtvorojenosti in malformacijah ter rezultatov epidemioloških študij (študija „primer-kontrola“ pri govedu, ovcah in kozah; študija o identifikaciji vira; študija o seroprevalenci; študija na poskusnih kontrolnih živalih), ki jih je treba zagotoviti za metaanalize rezultatov študij.
Joint epidemiological analysis with EFSA of data on SBV in Germany and other affected EU Member States including assessment of the impact of SBV on population dynamics, breeding management, and economy.
skupaj z Efso pripravljena epidemiološka analiza podatkov o virusu Schmallenberg v Nemčiji in drugih prizadetih državah članicah EU, ki vključuje oceno učinka virusa Schmallenberg na populacijsko dinamiko, upravljanje reje in gospodarstvo.
Determination of the within-herd prevalence and between-herd prevalence as well as the spatial distribution of SBV infections in different susceptible species.
Določanje razširjenosti znotraj čred in med njimi ter prostorske razporeditve okužb z virusom Schmallenberg pri različnih vrstah, dovzetnih za bolezen.
Analysis of the route of entry, transmission pathways, the source of the epidemic and its temporal development in Germany.
Analiza poti vnosa in prenosa, vira epidemije in njenega začasnega razvoja v Nemčiji.
Analysis of potential coincidence with animal density, herd/flock density, climate, and weather conditions, geography and ecological parameters.
Analiza možne povezave z gostoto živali, gostoto črede/jate, podnebjem in vremenskimi pogoji, geografskimi in ekološkimi parametri.
Member State involved: Germany
Sodelujoča država članica: Nemčija.
To identify clinical symptoms following SBV infection as well as potential risk factors for introduction and spread of SBV in dairy cattle herds and sheep.
Opredelitev kliničnih simptomov, ki sledijo okužbi z virusom Schmallenberg, ter možnih dejavnikov tveganja za vnos in širitev virusa Schmallenberg pri čredah krav molznic in ovcah.
Analysis of the impact of the SBV infection on health and productivity of dairy cattle and their offspring, the possibility of vertical transmission.
analiza učinka okužbe z virusom Schmallenberg na zdravje in produktivnost krav molznic in njihovih mladičev ter verjetnosti vertikalnega prenosa.
Determination of how long infected calves stay viraemic.
Ugotovitev, kako dolgo okužena teleta ostanejo viremična.
Guidance for potential control measures (e.g. grazing management).
Smernice za možne nadzorne ukrepe (npr. gospodarjenje s pašniki);
Description and quantification of clinical signs in adult infected sheep after a primary infection with SBV.
opis in količinska opredelitev kliničnih znakov pri odraslih okuženih ovcah po prvi okužbi z virusom Schmallenberg.
Determination of mortality rates in newborn lambs, relation between seroprevalence and clinical manifestations in herds.
Določitev stopnje umrljivosti pri novorojenih jagnjetih, povezanosti med seroprevalenco in kliničnimi manifestacijami pri čredah.
Identification of potential risk factors for introduction and spread of SBV in sheep flocks.
Opredelitev možnih dejavnikov tveganja za vnos in širjenje virusa Schmallenberg pri čredah ovac.
The study will obtain baseline information on impact of SBV on sheep health and production, and risk factors associated with introduction, spread and impact of SBV.
Študija bo zagotovila izhodiščne podatke o učinku virusa Schmallenberg na zdravje in proizvodnjo ovac ter o dejavnikih tveganja, povezanih z vnosom, širitvijo in učinkom virusa Schmallenberg.
Member State involved: the Netherlands
Sodelujoča država članica: Nizozemska.
Area 2 —
Področje 2 –
To clarify or exclude horizontal transmission by trying to provoke infection with most virulent virus (preferably not cell cultured).
Pojasnitev ali izključitev možnosti horizontalnega prenosa s poskusom povzročitve okužbe z najbolj virulentnim virusom (po možnosti ne pridobljenim s celično kulturo).
Determine if there are transmission routes without vector.
določitev, ali obstajajo poti prenosa brez vektorja.
Member States involved: Belgium, Germany, the Netherlands and the United Kingdom.
Sodelujoče države članice: Belgija, Nemčija, Nizozemska in Združeno kraljestvo.
To investigate which species are potential vectors for SBV by prospective and retrospective investigations.
Preučevanje, katere vrste so možni vektorji za virus Schmallenberg s prospektivnimi in retrospektivnimi preiskavami.
To confirm status of a series of suspected SBV vectors from affected countries and their ability to effectively transmit the virus.
potrditev statusa niza domnevnih vektorjev virusa Schmallenberg iz prizadetih držav in njihove sposobnosti za učinkovit prenos virusa.
Member States involved: Belgium, Germany, the Netherlands.
Sodelujoče države članice: Belgija, Nemčija, Nizozemska.
Coordinator: the Netherlands
Koordinatorica: Nizozemska.
To perform an experimental assessment of the rates of infection, dissemination and probable transmission in each vector group.
Izvajanje eksperimentalne ocene stopnje okužbe, širjenja in verjetnosti prenosa v posameznih skupinah vektorjev.
Epidemiological role played by the most common midge and mosquito species in transmitting SBV and assessment of the rates of infection, dissemination and probable transmission in each vector group.
epidemiološka vloga, ki jo imajo najbolj razširjene vrste trzač in komarjev pri prenosu virusa Schmallenberg, ter ocena stopnje okužbe, širjenja in verjetnosti prenosa v posameznih skupinah vektorjev.
Member States involved: Spain, France, Italy and the United Kingdom.
Sodelujoče države članice: Španija, Francija, Italija in Združeno kraljestvo.
Coordinator: Spain
Koordinatorica: Španija.
To investigate if bulls may excrete SBV in semen and to investigate risk of transmission via embryos by using frozen semen and in vitro fertilisation procedures with non-infected ovaries.
Preučevanje možnosti izločanja virusa Schmallenberg s semenom bikov ter tveganja prenosa prek zarodkov z uporabo zamrznjenega semena in postopkov oplojevanja in vitro z neokuženimi jajčniki.
Reliable information on the risk of transmission of SBV via semen and embryos.
zanesljivi podatki o tveganju prenosa virusa Schmallenberg s semenom in zarodki.
Determination of the role of other species (pigs, rabbits, mice or birds (chicken)) in the epidemiology of SBV.
Določitev vloge drugih vrst (prašičev, zajcev, miši ali ptic (kokoši)) pri epidemiologiji virusa Schmallenberg.
Identification of other species susceptible to SBV.
opredelitev drugih vrst, dovzetnih za virus Schmallenberg.
Coordinator: Belgium
Koordinatorica: Belgija.
Determination of the role of wildlife (deer, wild boar, etc.) in the epidemiology of SBV.
Določitev vloge prostoživečih živali (jelenjad, divji prašič itd.) pri epidemiologiji virusa Schmallenberg.
Clarify if the virus infects wildlife and if wildlife could play a role in the epidemiology of the virus.
pojasnitev, ali virus ogroža prostoživeče živali in ali bi prostoživeče živali lahko vplivale na epidemiologijo virusa.
Member States involved: Germany, the Netherlands and the United Kingdom.
Sodelujoče države članice: Nemčija, Nizozemska in Združeno kraljestvo.
Area 3 —
Področje 3 –
To develop SBV specific monoclonal antibodies for the development and evaluation of a competitive or blocking enzyme-linked immunosorbent assay (ELISA) to detect SBV specific antibodies in sera.
Razvoj specifičnih monoklonalnih protiteles proti virusu Schmallenberg za razvoj in oceno kompetitivnega ali blok encimsko imunskega testa (ELISA) za ugotavljanje specifičnih protiteles proti virusu Schmallenberg v serumu.
Development of diagnostic assays to detect SBV specific antibodies.
razvoj diagnostičnih preskusov za ugotavljanje specifičnih protiteles proti virusu Schmallenberg.
Member States involved: France and the United Kingdom.
Sodelujoči državi članici: Francija in Združeno kraljestvo.
To harmonise the validation of the different RT-PCR methods for the detection of SBV
Usklajevanje potrjevanja različnih metod RT-PCR za ugotavljanje virusa Schmallenberg.
Common protocol and minimum criteria for the validation of molecular and serological diagnostic tools with the involvement of the private sector.
skupni protokol in minimalna merila za potrjevanje molekularnih in seroloških diagnostičnih orodij z vključevanjem zasebnega sektorja.
Coordinator: Germany
Koordinatorica: Nemčija.
Budget per project (in EUR)
Proračun za posamezni projekt (v EUR)
Area 1 —
Področje 1 –
Projects 1.1, 1.2 and 1.3
Projekti 1.1, 1.2 in 1.3
Travel costs linked to meetings
Potni stroški, povezani s sestanki
Overheads (7 %)
Režijski stroški (7 %)
Travel cost linked to meetings
Potni stroški, povezani s sestanki
Project 2.1, 2.2a, 2.3, 2.4 and 2.5
Projekti 2.1, 2.2a, 2.3, 2.4 in 2.5
(excl. 2.5)
(brez 2.5)
(excl. 2.2a, 2.4 and 2.5)
(brez 2.2a, 2.4 in 2.5).
(excl. 2.2a)
(brez 2.2a)
Project 3.1 and 3.2
Projekta 3.1 in 3.2
(excl. 3.1)
(brez 3.1)
Staff costs shall be limited to actual attributable labour costs (remuneration, wages, social charges and retirement costs) accrued in implementation of the study.
Stroški osebja so omejeni na dejanske pripisljive stroške dela (osebni prejemki, plače, prispevki za socialno varnost in pokojninsko zavarovanje), nastale pri izvajanju študije.
To this end monthly time sheets have to be maintained.
V ta namen je treba voditi mesečne evidence prisotnosti.
Daily rate will be calculated on a 220 working days/year.
Dnevna postavka bo izračunana na podlagi 220 delovnih dni na leto.
Reimbursement is to be based on actual costs incurred for laboratory tests:
Povračilo temelji na dejanskih stroških, nastalih pri laboratorijskih preskusih:
the purchase of test kits, reagents and all consumables identifiable and especially used to carry out the laboratory test.
nakup kompletov za preskušanje in vsega potrošnega materiala, določljivega in uporabljenega posebej za izvajanje laboratorijskih preskusov.
Reimbursement is to be based on actual costs incurred for the
Povračilo temelji na dejanskih stroških, nastalih pri:
purchase of animals at market value,
nakupu živali po tržnih vrednostih,
transport to facilities and housing and feeding,
prevozu v objekte ter nastanitvi in krmljenju,
rendering of animals used in the experiments.
oskrbi živali, uporabljenih v poskusih.
All other expenditure on administration and secretarial services is considered to be covered by ‘overheads’.
Za vse druge odhodke, povezane z upravnimi in tajniškimi storitvami, se šteje, da so zajeti v „režijske stroške“.
Meetings (travel costs)
Sestanki (potni stroški)
Travel and hotel costs incurred by the staff for the participation to meetings related to the studies are eligible in accordance with the rules laid down in Annex IV to Commission Implementing Regulation (EU) No 926/2011 [1].5.
Potni stroški in stroški za hotel, nastali pri udeležbi osebja na sestankih v zvezi s študijami, so upravičeni v skladu s pravili iz Priloge IV k Izvedbeni uredbi Komisije (EU) št. 926/2011 [1].5.
A flat rate contribution of 7 % of actual eligible costs, calculated on the basis of all direct costs listed in items 1 to 4, may be claimed.
Lahko se zahteva pavšalni prispevek v višini 7 % dejanskih upravičenih stroškov, izračunan na podlagi vseh zgoraj neposrednih stroškov, navedenih v postavkah od 1 do 4.
The expenditure submitted by the Member States for a financial contribution by the Union shall be expressed in euro and shall exclude value added tax (VAT) and all other taxes.
Odhodki, ki jih države članice predložijo za finančni prispevek Unije, so izraženi v eurih ter izključujejo davek na dodano vrednost (DDV) in vse druge davke.
Member States may adjust the estimated budgets listed in Annex II by transfer between headings of eligible costs, provided that this adjustment of expenditure does not affect the implementation of the study, and without exceeding the total eligible cost per project.
Države članice lahko prilagodijo ocenjene proračune iz Priloge II s prenosom sredstev med postavkami upravičenih stroškov, če ta prilagoditev odhodkov ne vpliva na izvedbo študije ter niso preseženi skupni upravičeni stroški za posamezni projekt.